In this case report, M. van Rens, member of the NEVAT together with his colleagues, reports on a case of a term baby who postroutine insertion of a peripherally intravenous catheter showed an extreme reaction to extravasation of the administered intravenous fluids. They discuss the condition, their successful management with hyaluronidase, and the need to remain observationally vigilant of intravenous infusions despite the advances in infusion monitoring technology.
Authors :
Matheus van Rens, RN, MaANP (ORCID 0000-0001-9359-0895) Nursing and Vascular Access, Neonatal Intensive Care Unit, Women’s Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar
Kevin Hugill, RN, BSc, MSc, PhD (ORCID 0000-0002-3096-9635) Nursing and Midwifery Education Department, Hamad Medical Corporation, Doha, Qatar
Airene L. V. Francia, RN, BSc (ORCID 0000-0003-0698-1498) Vascular Access and Neonatal Transport, Neonatal Intensive Care Unit, Women’s Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar
Abdellatif Hamdy Abdelwahab, MD (ORCID 0000-0003-1724-8750) Neonatal Intensive Care Unit, Women’s Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar
Krisha L. P. Garcia, RN, BSc (ORCID 0000-0001-8041-8551) Neonatal Intensive Care Unit, Women’s Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar
Correspondence concerning this article should be addressed to matheusvanrens@gmail.com
Copyright © 2021 Association for Vascular Access.
